Newer Oral Antiviral for the Treatment of COVID-19 Infection

Sonia Singh, Drishty Surati, Madhav Kumar Savaliya, Ramesh Surati, Kruti Panchal

Open source

DOI
10.9734/jpri/2024/v36i97574
Published
2024-08-22
Container
Journal of Pharmaceutical Research International
Publisher
Sciencedomain International
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.9734/jpri/2024/v36i97574,
  title = {Newer Oral Antiviral for the Treatment of COVID-19 Infection},
  author = {Sonia Singh and Drishty Surati and Madhav Kumar Savaliya and Ramesh Surati and Kruti Panchal},
  year = {2024},
  journal = {Journal of Pharmaceutical Research International},
  doi = {10.9734/jpri/2024/v36i97574},
  url = {https://doi.org/10.9734/jpri/2024/v36i97574}
}

RIS

TY  - JOUR
TI  - Newer Oral Antiviral for the Treatment of COVID-19 Infection
AU  - Sonia Singh
AU  - Drishty Surati
AU  - Madhav Kumar Savaliya
AU  - Ramesh Surati
AU  - Kruti Panchal
PY  - 2024
JO  - Journal of Pharmaceutical Research International
DO  - 10.9734/jpri/2024/v36i97574
UR  - https://doi.org/10.9734/jpri/2024/v36i97574
ER  - 

APA

Singh, S., Surati, D., Savaliya, M. K., Surati, R., & Panchal, K. (2024). Newer Oral Antiviral for the Treatment of COVID-19 Infection. Journal of Pharmaceutical Research International. https://doi.org/10.9734/jpri/2024/v36i97574

Source records